NEUROCRINE BIOSCIENCES INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Neurocrine Biosciences Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Neurocrine Biosciences Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $88.9M, a 32.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $88.9M +$21.9M +32.7% Dec 31, 2023 10-K 2024-02-09
Q4 2022 $67M +$12.2M +22.3% Dec 31, 2022 10-K 2024-02-09
Q4 2021 $54.8M +$5M +10% Dec 31, 2021 10-K 2023-02-09
Q4 2020 $49.8M -$296M -85.6% Dec 31, 2020 10-K 2022-02-11
Q4 2019 $346M +$10.8M +3.22% Dec 31, 2019 10-K 2021-02-05
Q4 2018 $335M +$4.3M +1.3% Dec 31, 2018 10-K 2020-02-07
Q4 2017 $331M -$133M -28.6% Dec 31, 2017 10-K 2019-02-08
Q4 2016 $464M +$81.1M +21.2% Dec 31, 2016 10-K 2018-02-13
Q4 2015 $382M +$15.3M +4.17% Dec 31, 2015 10-K 2017-02-14
Q4 2014 $367M +$25.4M +7.43% Dec 31, 2014 10-K 2016-02-11
Q4 2013 $342M +$20.5M +6.38% Dec 31, 2013 10-K 2015-02-09
Q4 2012 $321M -$4.1M -1.26% Dec 31, 2012 10-K 2014-02-11
Q4 2011 $325M Dec 31, 2011 10-K 2013-02-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.